ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,070Medicare Part D Prescriptions Filled, Including Refills

Rank: 58 out of 387

$687K Total Retail Price of All Prescriptions

Rank: 78 out of 387

596 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 596 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

16% of this provider’s 596 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

3% of this provider’s 10,577 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
LEVOTHYROXINE SODIUM 594 466 1 2
AMLODIPINE BESYLATE 407 333 2 6
LISINOPRIL 402 341 3 3
HYDROCODONE-ACETAMINOPHEN 370 293 S3 4 1
OMEPRAZOLE 336 251 5 4
SIMVASTATIN 334 297 6 5
PRAVASTATIN SODIUM 321 267 7 15
HYDROCHLOROTHIAZIDE 290 236 8 12
CITALOPRAM HBR 288 244 9 19
METOPROLOL TARTRATE 268 229 10 11
ZOLPIDEM TARTRATE 250 180 11 16
FUROSEMIDE 245 202 12 7
METFORMIN HCL 231 200 13 8
METOPROLOL SUCCINATE 228 187 14 18
AMLODIPINE BESYLATE-BENAZEPRIL 221 202 15 54
GLIMEPIRIDE 188 173 16 50
GABAPENTIN 181 138 17 10
POTASSIUM CHLORIDE 173 166 18 9
MELOXICAM 155 117 19 22
BISOPROLOL-HYDROCHLOROTHIAZIDE 145 116 20 144
PROAIR HFA 140 114 21 47
CARVEDILOL 139 120 22 21
LISINOPRIL-HYDROCHLOROTHIAZIDE 129 99 23 30
ATENOLOL 127 127 24 20
DIOVAN 124 103 25 33
LOSARTAN POTASSIUM 123 122 26 24
ATORVASTATIN CALCIUM 120 114 27 13
LOVASTATIN 116 104 28 36
TRIAMTERENE-HCTZ 107 107 29 55
CRESTOR 103 91 30 34
TRAMADOL HCL 100 77 31 14
CYCLOBENZAPRINE HCL 97 57 R 32 42
TRIAMTERENE-HYDROCHLOROTHIAZID 92 55 33 186
SERTRALINE HCL 92 80 33 23
FLUOXETINE HCL 90 65 35 46
AMITRIPTYLINE HCL 90 63 R 35 62
DIOVAN HCT 82 82 37 74
VENLAFAXINE HCL ER 81 67 38 97
NEXIUM 81 78 38 26
LYRICA 79 61 40 66
FLUTICASONE PROPIONATE 74 59 41 29
SYNTHROID 74 74 41 68
TRAZODONE HCL 72 61 43 37
WARFARIN SODIUM 70 64 44 17
ENALAPRIL MALEATE 69 44 45 69
LOSARTAN-HYDROCHLOROTHIAZIDE 69 67 45 65
PLAVIX 67 60 47 39
KLOR-CON M20 65 43 48 76
CLOPIDOGREL 65 59 48 25
ESTRADIOL 64 46 R 50 105
LANTUS SOLOSTAR 64 51 50 102
MIRTAZAPINE 63 61 52 64
CYMBALTA 63 25 52 44
LANSOPRAZOLE 61 56 54 141
SINGULAIR 61 40 54 83
GEMFIBROZIL 61 54 54 93
ISOSORBIDE MONONITRATE ER 59 48 57 59
ALLOPURINOL 58 34 58 28
BENICAR 57 44 59 165
BYSTOLIC 55 54 60 112
TAMSULOSIN HCL 53 45 61 32
DIGOXIN 52 42 62 40
PAROXETINE HCL 51 33 63 52
ADVAIR DISKUS 51 31 63 41
VENTOLIN HFA 50 41 65 142
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 28, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.